Athira pharma reports third quarter 2024 financial results and pipeline and business updates

Expects to complete healthy volunteer phase 1 clinical study of ath-1105 by year end and begin dosing als patients in 2025 expects to complete healthy volunteer phase 1 clinical study of ath-1105 by year end and begin dosing als patients in 2025

ATHA Ratings Summary

ATHA Quant Ranking